As ADAM17-mediated promotion of angiogenesis was reported to involve sMCAM release [31,33,38,40], we aimed to unravel how ADAM17 inhibition could also affect MC38 mouse colorectal tumor angiogenesis and lymphangiogenesis. The gene discussed is ADAM17; the disease is colorectal neoplasm.